###begin article-title 0
###xml 30 37 30 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vivo</italic>
###xml 22 26 <span type="species:ncbi:10090">Mice</span>
ZAP-70 Restoration in Mice by In Vivo Thymic Electroporation
###end article-title 0
###begin p 1
Conceived and designed the experiments: CN MI MS FB. Performed the experiments: MI MS AK LP. Analyzed the data: LL PM EJ. Wrote the paper: CN MI MS.
###end p 1
###begin p 2
Current address: Department of Pathology and Immunology, University of Geneva Medical School, Centre Medical Universitaire, Geneva, Switzerland
###end p 2
###begin p 3
These authors also contributed equally to this work.
###end p 3
###begin p 4
###xml 317 324 317 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 981 988 981 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 544 548 <span type="species:ncbi:10090">mice</span>
###xml 628 632 <span type="species:ncbi:10090">mice</span>
Viral and non-viral vectors have been developed for gene therapy, but their use is associated with unresolved problems of efficacy and safety. Efficient and safe methods of DNA delivery need to be found for medical application. Here we report a new monopolar system of non-viral electro-gene transfer into the thymus in vivo that consists of the local application of electrical pulses after the introduction of the DNA. We assessed the proof of concept of this approach by correcting ZAP-70 deficient severe combined immunodeficiency (SCID) in mice. The thymic electro-gene transfer of the pCMV-ZAP-70-IRES-EGFP vector in these mice resulted in rapid T cell differentiation in the thymus with mature lymphocytes detected by three weeks in secondary lymphoid organs. Moreover, this system resulted in the generation of long-term functional T lymphocytes. Peripheral reconstituted T cells displayed a diversified T cell receptor (TCR) repertoire, and were responsive to alloantigens in vivo. This process applied to the thymus could represent a simplified and effective alternative for gene therapy of T cell immunodeficiencies.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 877 880 869 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Fischer1">[1]</xref>
###xml 987 990 979 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Fischer2">[2]</xref>
###xml 1317 1320 1309 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Kohn1">[3]</xref>
###xml 527 531 <span type="species:ncbi:10090">mice</span>
###xml 536 542 <span type="species:ncbi:9606">humans</span>
###xml 715 720 <span type="species:ncbi:9606">human</span>
The thymus is the primary site of generation of functional T lymphocytes. After maturation, T cells are released into the bloodstream and lymph fluid and then migrate to secondary lymphoid organs, mainly the spleen and lymph nodes. T lymphocytes play a crucial role in adaptative immune responses by recognizing antigens derived from pathogens or tumor cells. Adaptative immune responses may be impaired in several ways, including the natural mutations characterized by blocks in T cell development that have been described in mice and humans. These disorders are known collectively as SCIDs, because the clinical consequence is a devastating predisposition to infections and cancers. At least 9 different forms of human SCIDs have now been recognized and can be grouped according to genes involved such as gammac, ADA, Artemis, ZAP-70, JAK-3, IL7Ralpha, CD45, RAG-1 and RAG-2 [1]. Gene therapy appears to be an appealing treatment by inserting corrective transgenes into abnormal cells [2]. Recombinant viruses are effective vectors for transferring genes into haematopoietic precursors. However, the main limitations reside in the possible development of opportunist cancers and in the potential toxicity in peripheral lymphocytes of the gene expression system controlled by retroviral long terminal repeats (LTRs) [3].
###end p 6
###begin p 7
###xml 262 265 262 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Gehl1">[4]</xref>
###xml 405 412 405 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 502 505 502 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Prudhomme1">[5]</xref>
###xml 590 597 590 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 892 895 892 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Gehl1">[4]</xref>
Gene therapy thus requires more efficient alternative therapeutic methods, using non-viral vectors in conjunction with an effective and safe physical process. Applying an electric field to cells and tissues significantly increases DNA uptake and gene expression [4]. Electroporation is usually performed by locally injecting DNA to the site of interest followed by the application of an electrical field. In vivo, electroporation has been already performed on several tissues, notably muscle and liver [5]. However, to our knowledge the thymus has never been electrotransfected. Therefore, in vivo electroporation of thymus appears to be a promising method to circumvent severe immunodeficiencies. Classical processes are aggressive using bipolar and even multipolar electrodes, often involving incisions, and the success of gene transfer may be compromised by aggressive surgical procedures [4].
###end p 7
###begin p 8
###xml 118 125 118 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 622 623 622 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 626 627 626 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 675 678 675 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Kadlecek1">[6]</xref>
###xml 704 711 704 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 744 747 744 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 789 790 789 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 798 799 798 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 442 448 <span type="species:ncbi:10090">murine</span>
###xml 748 752 <span type="species:ncbi:10090">mice</span>
Here, we describe a new method of electroporation without any incision, using a monopolar device to target the thymus in vivo. We stably electro-gene transferred thymocytes during their maturation in the thymus. We found the corresponding mature transfected T lymphocytes correctly localized in T zones of lymph nodes and spleen one month following treatment. We evaluated the usefulness of this approach to treat thymus-linked SCIDs using a murine model of ZAP-70 deficiency. ZAP-70 is a protein tyrosine kinase crucially involved in T cell differentiation. Its absence results in a SCID phenotype with a block at the CD4+CD8+ double-positive early stage of differentiation [6]. ZAP-70 gene transfer by in vivo thymic electroporation in ZAP-70-/- mice results in the reconstitution of CD4+ and CD8+ single-positive thymocytes and the long-term detection of a high number of peripheral T lymphocytes displaying a diversified TCR repertoire and normal functional properties.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 47 54 47 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
A simple procedure to electroporate the thymus in vivo
###end title 10
###begin p 11
###xml 76 83 76 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 272 281 272 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g001">Figure 1A</xref>
###xml 646 655 640 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g001">Figure 1A</xref>
###xml 1107 1117 1097 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002059.s001">Figure S1A</xref>
###xml 1198 1205 1188 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
###xml 389 394 <span type="species:ncbi:10090">mouse</span>
###xml 1000 1004 <span type="species:ncbi:10090">mice</span>
The target organ is the mouse thymus. To transfect this deep organ directly in vivo without surgical intervention, we developed an electroporation procedure based on a monopolar device using a single needle as anode to inject the plasmid DNA and apply the electric field (Figure 1A). The needle size was calibrated according to the animal size and thymus localization. On an anaesthetized mouse, a crocodile clip corresponding to the cathode, establishes skin contact on the paw opposite to the injection site. We introduced the needle between the first and the second rib keeping the angle of the needle at 45degrees from the longitudinal axis (Figure 1A, inset). Thereafter, a volume of 10 microl of highly concentrated plasmid DNA was slowly injected in one thymic lobe and the current was immediately delivered. The second lobe was then treated in the same way. This technique allows electrotransfection of the thymus without affecting vital proximal organs such as the heart and lung, since all mice survived the intervention. Impact points on each thymic lobe were observed following electroporation (Figure S1A). Therefore, we established a safe simple procedure to electroporate the thymus in vivo.
###end p 11
###begin title 12
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Monopolar electroporation of the thymus in anaesthetized mice.
###end title 12
###begin p 13
###xml 735 739 <span type="species:ncbi:10090">mice</span>
###xml 752 756 <span type="species:ncbi:10090">mice</span>
###xml 773 777 <span type="species:ncbi:10090">mice</span>
###xml 847 851 <span type="species:ncbi:10090">mice</span>
###xml 1012 1016 <span type="species:ncbi:10090">mice</span>
(A) Bold dotted lines indicate the angle of axis legs. The needle (optimal size: 3 mm) is inserted between the two first ribs, under the ribcage, following the angle of the paw parallel to the benchtop. The stimulating syringe, delivering electric pulses and plasmid DNA, represents the anodic electrode. The cathodic pole is represented by a crocodile clip attached to the paw of the side opposite to the injection point. The inset represents a schematic representation of the needle insertion through the ribcage to inject the thymus. (B) Luciferase activity in the thymus 24 hours after injection with or without electroporation. 10 microg of luciferase DNA plasmid in a volume of 10 microl was injected into each thymic lobe of 10 mice for 0 V, 10 mice for 300 V and 5 mice for all other voltages. Whatever the electric intensity applied, all mice survived. (C) Luciferase activity 24 hours (h) and one month after injection in the thymus without or with electroporation at 300 and 600 V, respectively. Four mice were analyzed for each condition.
###end p 13
###begin title 14
Optimization of electrical parameters
###end title 14
###begin p 15
###xml 202 205 194 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Vicat1">[7]</xref>
###xml 430 439 422 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g001">Figure 1B</xref>
###xml 660 667 652 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 685 695 677 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002059.s001">Figure S1B</xref>
Previous in vivo electroporation analyses on the most widely targeted tissue which is skeletal muscle have shown that an effective conditions is 5 pulses of 1 Hz, at 100 microsec, with 10 microg of DNA [7]. Based on "muscle" parameters in combination with different voltages ranging from 0 to 900 V, we determine the optimal voltage to electrotransfect the thymus by transfecting the pCMV-luciferase (pCMV-luc) expression vector (Figure 1B). Maximal gene expression 24 hours after electroporation was achieved at 300 V. The amount of luciferase was increased 30-fold compared to the control condition (0 V). Moreover, we confirmed the transfection efficacy by in vivo bioluminescence (Figure S1B).
###end p 15
###begin p 16
###xml 189 198 189 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g001">Figure 1C</xref>
###xml 635 638 635 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Berzins1">[8]</xref>
###xml 738 741 738 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Palmer1">[9]</xref>
###xml 785 792 785 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
To assess whether these parameters result in a stable transfection, we investigated luciferase expression one month after injection or electroporation at 300 and 600 V of pCMV-luc plasmid (Figure 1C). We observed a complete absence of luciferase expression at 0 and 600 V. In contrast, at 300 V the luciferase expression was still detected although decreased five fold relative to 24 hours post-electroporation. This decrease can be partly explained by two physiological processes of the thymus. Firstly, the T cell maturation in the thymus takes about one month and mature T lymphocytes then migrate towards secondary lymphoid organs [8]. Secondly, approximately 90% of thymocytes are eliminated by apoptosis during selection mechanisms [9]. Altogether, these results showed that the in vivo thymic electroporation at 300 V leads to an efficient and stable transfection.
###end p 16
###begin title 17
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Differentiating thymocytes are transfected in vivo
###end title 17
###begin p 18
###xml 202 210 198 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g002">Figure 2</xref>
###xml 470 479 466 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g002">Figure 2A</xref>
###xml 556 565 552 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g002">Figure 2B</xref>
###xml 667 676 663 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g002">Figure 2C</xref>
###xml 750 759 746 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g002">Figure 2D</xref>
###xml 891 903 887 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g002">Figure 2E, F</xref>
We determined the distribution of transfected thymic cells by confocal microscopy. 10 microg of pCMV-Enhanced Green Fluorescent Protein (EGFP) expression vector was injected or electroporated at 300 V (Figure 2). Detailed observation of thymic sections revealed no necrosis or any sign of tissue damage near the injection site, suggesting that the procedure was well tolerated (data not shown). As expected, sections of the non-injected thymus exhibited no EGFP signal (Figure 2A). In contrast, after 24 hours, a weak uniform staining was observed at 0 V (Figure 2B); while at 300 V the signal was stronger and numerous clusters of transfected cells were visualized (Figure 2C). These results were also confirmed by immunohistochemistry experiments (Figure 2D). One month later, the level of transfected cells strongly decreased, which is consistent with luciferase results described above (Figure 2E, F). Moreover, transfected cells were localized in several distinct clusters localized around venules of the cortico-medullary region suggesting that transfected cells could be thymocytes at the end stage of maturation on their way to be exported to the periphery.
###end p 18
###begin title 19
Distribution and immunophenotype of EGFP transfected thymocytes in electroporated thymi.
###end title 19
###begin p 20
Sections of thymi that were: (A) non injected; (B) injected without electroporation after 24 hours and (C) electroporated at 300 V after 24 hours were analyzed for the EGFP expression signal by confocal microscopy. Each image was captured and processed under the same conditions with a 10X objective. (D) 20X view of immunohistochemistry analysis using an anti-EGFP antibody of a thymus electroporated with the EGFP DNA plasmid at 300 V after 24 hours. (E) After one month, a nuclear counterstain (DAPI, blue) shows that these transfected cells are localized around blood vessels near the cortico-medullary junction (CMJ). (F) 20X view of immunohistochemistry analysis using an anti-EGFP antibody shows numerous transfected cells in the medulla after one month. Arrows indicate the EGFP expression signal. Abbreviations: c = cortex, m = medulla, v = venule. (G) Thymocyte profile stained with CD4 and CD8 monoclonal antibodies was analyzed by flow cytometry after 24 hours thymic electroporation. The percentage of cells within each quadrant is indicated. The different populations of thymocytes expressing EGFP protein in wild-type, 0 V and 300 V electroporated thymus were analyzed. The percentage of EGFP transfected cells is indicated within the quadrant of each population.
###end p 20
###begin p 21
###xml 317 326 313 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002059.s002">Figure S2</xref>
###xml 594 598 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Ushiki1">[10]</xref>
Three independent experiments were performed to confirm this hypothesis, by co-staining lymphocytes using the CD3 marker which labeled nearly the whole thymocyte populations (DN to SP). We observed that 3.6+/-0.8% of T cells are transfected in the cortex and 1.9+/-0.7% in the medulla 24 hours after electroporation (Figure S2). After one month, we still detected 1.1+/-0.4% of T cells in the medulla and at the cortico-medullary junction, but none in the cortex. This observation is consistent with the fact that mature thymocytes congregate near blood vessels to be exported to the periphery [10].
###end p 21
###begin p 22
###xml 126 127 126 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 130 131 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 157 158 157 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 161 162 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 194 195 194 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 198 199 198 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 207 208 207 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 211 212 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 268 277 268 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g002">Figure 2G</xref>
###xml 398 399 398 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 407 408 407 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 647 651 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-ZunigaPflucker1">[11]</xref>
###xml 714 718 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Anderson1">[12]</xref>
To immunophenotype EGFP transfected thymocytes, we analyzed EGFP expression within the four main thymocyte subpopulations (CD4-CD8- double-negative (DN), CD4+CD8+ double-positive (DP) stage, CD4+CD8- and CD4-CD8+ single-positive (SP) by flow cytometry after 24 hours (Figure 2G). We found similar percentages of transfection obtained by confocal microscopy (6.72% of DN, 2.82% of DP and 4.4% of CD4+ and CD8+ SP cells). As expected, we did not observe any significant transfection in the 0 V condition. Moreover, we deduced that thymocytes in cell cycle may be preferentially transfected such as DN thymocytes that undergo extensive proliferation [11] and SP thymocytes that expand the newly selected T repertoire [12]. Finally, while thymocytes are difficult to transfect using a non viral system, our method allows their transfection with reasonable success, and the expression of the transfected gene is observed in the main thymocyte subpopulations.
###end p 22
###begin title 23
###xml 78 85 78 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Transfected T cells are detected in secondary lymphoid organs one month after in vivo thymic electroporation
###end title 23
###begin p 24
###xml 156 164 156 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g003">Figure 3</xref>
###xml 278 290 278 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g003">Figure 3A, B</xref>
###xml 360 369 360 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g003">Figure 3C</xref>
###xml 695 699 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Grayson1">[13]</xref>
###xml 701 710 701 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g003">Figure 3B</xref>
###xml 878 882 878 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-vonAndrian1">[14]</xref>
###xml 884 893 884 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g003">Figure 3D</xref>
To determine whether transfected thymocytes develop into mature T cells, we analyzed spleen sections by two methods one month after thymic electroporation (Figure 3). Numerous EGFP cells were detected in the white pulp as shown by a DAPI counterstaining in confocal microscopy (Figure 3A, B), and confirmed by immunohistochemistry using an anti-EGFP antibody (Figure 3C). This observation is consistent with successful transfection of thymocytes in the thymus, and shows that transfected mature thymocytes were exported to the spleen. Moreover, a detailed observation showed that some transfected T cells are localized around a central arteriole suggesting that these cells are fresh immigrants [13] (Figure 3B; inset). The same analysis was also performed in lymph-nodes by labeling high endothelial venules with the PNAd antibody that recognizes the peripheral node addressin [14] (Figure 3D). We observed that incoming EGFP transfected T cells were found around venules.
###end p 24
###begin title 25
Detection of EGFP positive T lymphocytes in T zones of the spleen and lymph-nodes one month after thymic electroporation.
###end title 25
###begin p 26
###xml 1096 1103 1096 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">methods</xref>
(A) Fluorescence analysis at 100X view of a splenic internal region reveals EGFP positive cells. (B) A nuclear counterstain (DAPI, blue) shows that these positive cells are localized in the white pulp. Insets represent a higher magnification at 400X view of the central arteriole area (ca) where a cluster of EGFP positive cells is observed. (C) 100X view of spleen immunohistochemistry analysis using an anti-EGFP antibody shows the distribution of transfected cells (arrows). (D) EGFP positive cells are localized near high endothelial venules (HEVs) stained with an anti-PNAd antibody (red) in lymph-nodes. (E) Sections of lymph-nodes and the spleen were analyzed by confocal microscopy after staining with a B cell specific antibody (B220) and an anti-CD3 antibody that specifically reacts with T lymphocytes. Multiple representative clusters of EGFP transfected cells were found mainly in T zones of different lymph-nodes and spleen sections. (F) Percentages of EGFP transfected CD3 positive T lymphocytes present within T zones of lymph-nodes and the spleen were calculated as described in methods. The mean percentage and the standard deviation of 3 individual organs (n = 3) were calculated. Abbreviations: wp = white pulp, rp = red pulp, ca = central arteriole, v = vessel.
###end p 26
###begin p 27
###xml 310 319 310 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g003">Figure 3E</xref>
###xml 571 580 567 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g003">Figure 3F</xref>
These secondary lymphoid organs are organized in both T and B cell zones. To ensure that transfected T cells had correctly migrated into T cell zones, a co-staining analysis was performed on spleen and lymph-nodes sections by using anti-B220 and anti-CD3 antibodies to detect B and T cell areas, respectively (Figure 3E). B cell areas were mostly EGFP negative while T cell zones show numerous EGFP positive cells. We quantified the number of EGFP transfected lymphocytes using the CD3 marker and observed 1.0+/-0.2% of cells in lymph nodes and 1.5+/-0.2% in the spleen (Figure 3F).
###end p 27
###begin p 28
Consequently, T cells were stably electroporated in the thymus, since significant numbers of transfected T lymphocytes were detected around homing sites and in T zones of secondary lymphoid organs one month later.
###end p 28
###begin title 29
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Restoration of thymic development in ZAP-70-/- mice after electroporation
###end title 29
###begin p 30
###xml 261 262 261 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 265 266 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 276 279 276 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Kadlecek1">[6]</xref>
###xml 281 285 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Negishi1">[15]</xref>
###xml 536 539 536 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 715 719 715 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Mir1">[16]</xref>
###xml 954 963 954 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g004">Figure 4A</xref>
###xml 1140 1143 1140 1143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 1191 1198 1191 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1434 1443 1434 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g004">Figure 4A</xref>
###xml 106 112 <span type="species:ncbi:10090">murine</span>
###xml 306 311 <span type="species:ncbi:10090">mouse</span>
###xml 447 450 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 1306 1310 <span type="species:ncbi:10090">mice</span>
We assessed the usefulness of this new approach to correct a thymus-linked immunodeficiency. We chose the murine model of Zeta-chain (TCR) Associated Protein kinase (ZAP-70) deficient SCID, which exhibits a relatively late block in T cell development at the CD4+CD8+ DP stage [6], [15]. We constructed the mouse ZAP-70/internal ribosome entry site/enhanced GFP (ZAP-70-IRES-EGFP) cassette under the transcriptional control of the cytomegalovirus (CMV) promoter. In this context, ZAP-70 and EGFP expression is concordant. Thymi of ZAP-70-/- mice were electroporated with this expression vector at the optimal voltage of 300 V with a pulse length of 20 ms because longer pulse lengths improved transfection of muscle [16] as confirmed by our results for this gene in the thymus (data not shown). Transfection efficacy was evaluated after 48 hours by analyzing levels of ZAP-70 mRNA and protein in total thymocytes by RT-PCR and western-blot, respectively (Figure 4A, upper panel). As expected, the ZAP-70 mRNA (left panel) and protein (right panel) were clearly detected in wild-type (WT) thymocytes while no expression was observed in ZAP-70-/- thymocytes. In contrast, total thymocytes from in vivo electroporated thymus expressed the ZAP-70 transgene, albeit more weakly than the endogenous protein in WT mice. ZAP-70 and EGFP ectopic expression were further studied by determining their distribution pattern by confocal microscopy (Figure 4A, lower panel). Numerous transfected cells that co-expressed ZAP-70 and EGFP proteins were detected in the thymus, confirming the successful transfection.
###end p 30
###begin title 31
###xml 31 34 31 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 50 57 50 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
T cell reconstitution in ZAP-70-/- mice following in vivo thymic electroporation with the pCMV-ZAP-70-IRES-EGFP DNA plasmid.
###end title 31
###begin p 32
###xml 113 120 113 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 180 183 180 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 341 348 341 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 635 638 635 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 755 758 755 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 930 931 930 931 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 939 940 939 940 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1003 1006 1003 1006 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 1034 1035 1034 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 639 643 <span type="species:ncbi:10090">mice</span>
###xml 759 763 <span type="species:ncbi:10090">mice</span>
###xml 981 985 <span type="species:ncbi:10090">mice</span>
###xml 1007 1011 <span type="species:ncbi:10090">mice</span>
(A) The upper panel shows ZAP-70 mRNA (left panel) and protein (right panel) levels in total thymocytes from WT, in vivo electroporated thymus at 300 V after 48 hours and in ZAP-70-/- deficient mice assessed by RT-PCR and western-blot, respectively. The lower panel shows the distribution of ZAP-70 and EGFP proteins analyzed 48 hours after in vivo electroporation of the pCMV-ZAP-70-IRES-EGFP DNA plasmid by confocal microscopy (upper panel, 100X view). A higher magnification of transfected thymocytes is also presented (400X view). (B) Thymocyte profiles stained with CD4 and CD8 monoclonal antibodies were analyzed in WT and ZAP-70-/- mice electroporated at 300 V with the pCMV-ZAP-70-IRES-EGFP DNA plasmid after one and two weeks as well as in ZAP-70-/- mice. (C) three weeks after thymic electroporation, the presence of splenic T cells was monitored using CD4 and CD8 monoclonal antibodies (upper panel). Percentages of CD4+ and CD8+ T lymphocytes from WT and reconstituted mice as well as ZAP-70-/- mice are indicated. The CD3+ T lymphocytes profile was also analyzed by using a CD3 monoclonal antibody (lower panel). The percentages of positively stained cells are indicated in each histogram.
###end p 32
###begin p 33
###xml 166 169 166 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 219 222 219 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 229 238 229 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g004">Figure 4B</xref>
###xml 586 589 586 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
###xml 590 594 <span type="species:ncbi:10090">mice</span>
We then assessed the capacity of this transfection to restore thymocyte development. The CD4 and CD8 thymocyte profile was analyzed in WT and in electroporated ZAP-70-/- mice after one and two weeks as well as in ZAP-70-/- mice (Figure 4B). One week after electroporation, 2.1% of CD4 SP and 0.7% of CD8 SP were detected while after two weeks 5.8 and 4.4% were observed for CD4 and CD8 SP thymocytes, respectively. These results indicate that ZAP-70 expression driven from the electroporated pCMV-ZAP-70-IRES-EGFP DNA plasmid is capable of correcting the differentiation block in ZAP-70-/- mice.
###end p 33
###begin title 34
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Restoration of thymocyte development in ZAP-70-/- mice results in appearance of mature T cells in the periphery
###end title 34
###begin p 35
###xml 35 42 35 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 66 69 66 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 220 221 220 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 229 230 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 246 255 246 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g004">Figure 4C</xref>
###xml 472 473 472 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 489 498 489 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g004">Figure 4C</xref>
###xml 629 632 629 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 896 906 896 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002059.s003">Figure S3A</xref>
###xml 990 1000 990 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002059.s003">Figure S3A</xref>
###xml 1094 1096 1094 1096 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 1101 1103 1101 1103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 1188 1198 1188 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002059.s003">Figure S3B</xref>
###xml 1227 1231 1227 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Adjali1">[17]</xref>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
###xml 1182 1186 <span type="species:ncbi:10090">mice</span>
In an attempt to determine whether in vivo gene transfer in ZAP-70-/- thymi results in the appearance of mature T cells in the periphery, spleens were analyzed 3 weeks after thymic electroporation for the presence of CD4+ and CD8+ T lymphocytes (Figure 4C; upper panel). We detected considerable numbers of T lymphocytes in electroporated mice, reaching 11 and 7% for CD4 and CD8 T cells, respectively. Moreover, the same samples were also analyzed for the presence of CD3+ T lymphocytes (Figure 4C; lower panel). Similar results showing the appearance of a high level of T cells (24.5%) in electroporated mice compared to ZAP-70-/- mice (3.7%) were obtained. Identical results were also obtained in lymph nodes (data not shown). We observed by confocal microscopy using an anti-CD3 antibody that a large numbers of transfected T lymphocytes were detected specifically in the splenic white pulp (Figure S3A, upper panel). These cells are ZAP-70 positive, as shown by western blot analysis (Figure S3A, lower panel). Moreover, we showed that newly generated T cells exhibit a characteristic CD44hi CD62lo activated phenotype occurring during T cell reconstitution of immunodeficient mice (Figure S3B) as found by Adjali and all [17]. Altogether, these data demonstrate that the correction in ZAP-70 expression by electroporation results in the presence of mature T cells correctly localized in the periphery.
###end p 35
###begin title 36
###xml 76 79 76 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
T lymphocytes exhibit a diversed receptor repertoire in reconstituted ZAP-70-/- mice
###end title 36
###begin p 37
###xml 337 341 337 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Gallagher1">[18]</xref>
###xml 451 454 445 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 548 557 542 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g005">Figure 5A</xref>
###xml 616 625 610 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g005">Figure 5A</xref>
###xml 679 682 673 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 756 765 750 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g005">Figure 5A</xref>
###xml 965 974 959 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002059.s004">Figure S4</xref>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 683 687 <span type="species:ncbi:10090">mice</span>
###xml 863 867 <span type="species:ncbi:10090">mice</span>
###xml 959 963 <span type="species:ncbi:10090">mice</span>
To evaluate the quality of T cell repertoire in reconstituted mice, we used a quantitative PCR method that allows real time monitoring of PCR product appearance according to its relative abundance. We analyzed V alpha genes, which are highly expressed, such as V1, V2 and V3 and those that are less frequent, such as V5, V8, V14 and V17 [18]. The relative abundance of the transcripts was normalized to the CD3epsilon transcript. As expected in ZAP-70-/- thymic samples, TCRV transcript products were not detectable or present in very low amounts (Figure 5A, upper panel) while in the spleen they were not detected (Figure 5A, lower panel). Interestingly, in reconstituted ZAP-70-/- mice, all the TCRV transcripts tested were detected in thymus or spleen (Figure 5A). Moreover, we analyzed the size of the CDR3 of TCR transcripts for alpha chain in reconstituted mice, which showed polyclonal T cell population expressing a wide TCR repertoire as found in WT mice (Figure S4).
###end p 37
###begin title 38
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
TCR repertoire diversity in ZAP-70-/- electroporated mice.
###end title 38
###begin p 39
###xml 95 98 95 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 110 113 110 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 936 939 930 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 951 954 945 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 955 959 <span type="species:ncbi:10090">mice</span>
###xml 1463 1467 <span type="species:ncbi:10090">mice</span>
###xml 1495 1499 <span type="species:ncbi:10090">mice</span>
(A) Quantification of TCR V alpha transcripts in thymi and spleens between WT, untreated ZAP-70-/-, and ZAP-70-/- mice electroporated at 300 V. Two and three weeks after electroporation, thymic (upper panel) and splenic (lower panel) cDNAs were respectively amplified using oligonucleotides specific for CD3epsilon and for a set of oligonucleotides specific for each of the V alpha genes in conjunction with a primer specific of the constant region of TCR alpha chain. Histograms correspond to a representative amplification of two separate experiments. (B) Thymocyte profile stained with CD4 and CD8 monoclonal antibodies was analyzed by flow cytometry after 10 months thymic electroporation (left panel). The persistence of CD4 and CD8 T lymphocytes in the spleen was monitored by flow cytometry 10 month after thymic electroporation (right panel). (C) Quantification of TCR V alpha transcripts in spleens between WT, untreated ZAP-70-/-, and ZAP-70-/- mice with thymi electroporated at 300 V after 10 months. Splenic cDNA was amplified using oligonucleotides specific for CD3epsilon and for a set of oligonucleotides specific for each of the V alpha genes in conjunction with a primer specific of the constant region of TCR alpha chain. Histograms correspond to a representative amplification of two separate experiments. (D) TCRValpha2 and indicated TCRVbeta usage by splenic CD8 and CD4 T cells was evaluated by FACS analysis in eighteen month reconstituted mice compared to age-matched WT mice. Abbreviations: wks = weeks, mo = months.
###end p 39
###begin p 40
###xml 163 172 163 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g005">Figure 5B</xref>
###xml 248 249 248 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 260 261 260 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 270 279 270 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g005">Figure 5B</xref>
###xml 358 359 358 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 370 371 370 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 419 428 419 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g005">Figure 5B</xref>
###xml 656 665 640 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g005">Figure 5D</xref>
###xml 667 669 651 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002059.s005">S5</xref>
###xml 720 729 704 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002059.s005">Figure S5</xref>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
To monitor the persistence of T cells in reconstituted mice, we analyzed the CD4 and CD8 profile in the thymus and spleen ten months after thymic electroporation (Figure 5B). As expected, SP thymocytes were not detectable anymore in the thymus (CD4+: 0.7%; CD8+: 0.1%) (Figure 5B, left panel) while both types of T cells were still present in the spleen (CD4+: 7.5%; CD8+:7.4%) exhibiting a diversified TCR repertoire (Figure 5B, right panel, C). In addition, FACS analyses showed that TCR bearing Valpha2 and several Vbeta (Vbeta5.1-5.2, Vbeta8.1-8.2 and Vbeta11) persist among mature CD8 and CD4 splenic T cells eighteen months following reconstitution (Figure 5D, S5). Representative FACS dot plots are also shown in Figure S5.
###end p 40
###begin p 41
###xml 60 67 60 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
This indicates that T lymphocyte populations produced after in vivo thymic electroporation resulted from a wide variety of transfected thymocytes, which underwent thymic selection to generate a long-term diversified TCR repertoire.
###end p 41
###begin title 42
###xml 74 77 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
T lymphocytes exhibit normal functional properties in reconstituted ZAP-70-/- mice
###end title 42
###begin p 43
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 174 186 174 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g006">Figure 6A, B</xref>
###xml 346 355 346 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g006">Figure 6A</xref>
###xml 455 463 455 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 547 548 547 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 646 655 642 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g006">Figure 6A</xref>
###xml 674 675 670 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 739 748 735 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g006">Figure 6B</xref>
###xml 858 859 854 855 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 538 542 <span type="species:ncbi:10090">mice</span>
###xml 780 784 <span type="species:ncbi:10090">mice</span>
###xml 836 840 <span type="species:ncbi:10090">mice</span>
To evaluate in vivo the functionality of CD8 and CD4 T cells in long-term reconstituted mice, mice were vaccinated with DNA encoding the full-length ovalbumin (OVA) protein (Figure 6A, B). The percentage of circulating T lymphocytes was evaluated in each condition to monitor the persistence of T cells over sixteen months in reconstituted mice (Figure 6A, upper panel). Three weeks later, the anti-OVA CD8 response was analyzed on circulating T cells by in vitro stimulation with a specific OT-I peptide. In sixteen months reconstituted mice, CD8+ T cells exhibit a capacity similar to WT to produce IFN-gamma, reflecting a normal CD8 response (Figure 6A, lower panel). CD4+ T cells functionality was evaluated by anti-OVA IgG titration (Figure 6B). Sixteen months reconstituted mice produced a similar antibody level as WT vaccinated mice, showing that CD4+ T cells have the capacity to give a cooperative help signal to B cells. All together, these results indicate that both CD8 and CD4 T cells possess normal functional properties.
###end p 43
###begin title 44
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 74 77 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
In vivo responsiveness of reconstituted T lymphocytes in reconstituted ZAP-/- mice.
###end title 44
###begin p 45
###xml 291 292 291 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 476 477 472 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 665 668 661 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 850 853 846 849 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 1069 1072 1065 1068 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 1150 1153 1136 1139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 1419 1422 1387 1390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 1463 1466 1431 1434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 1992 1995 1960 1963 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 2090 2091 2058 2059 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
###xml 669 673 <span type="species:ncbi:10090">mice</span>
###xml 1154 1158 <span type="species:ncbi:10090">mice</span>
One year old reconstituted mice were vaccinated with a plasmid encoding for the full length OVA. (A) The percentage of circulating T lymphocytes was evaluated in each indicated condition (upper panel) to monitor the long-term persistence of T cells in reconstituted mice. The function of CD8+ T cells was assessed by an antigen presentation assay of OT-I peptide and the percentage of produced IFN-gamma was determined by intracellular FACS staining (lower panel). (B) The CD4+ T cell response following immunization was indirectly evaluated by measuring the level of anti-OVA IgG produced in reconstituted vs. WT mice (right panel). (C-I) Reconstituted C57BL/6 ZAP-/- mice rapidly rejected fully MHC-mismatched BALB\c skin grafts. (C) Survival curves for allogeneic BALB/c skin grafts on C57BL/6 seven and sixteen months following reconstitution ZAP-/- recipients (*) show rejection between day 10 and day 14, as fast as the allogeneic control (o). However, survival curves for syngeneic C57BL/6 skin grafts are similar in both the C57BL/6 WT () and the untreated ZAP-/- recipients (triangle up) to allogeneic BALB/c skin grafts on untreated ZAP-70-/- mice (black triangle down), which don't show any graft rejection. Histological sections were performed of syngeneic (C57BL/6) skin that was grafted on WT C57BL/6 recipients (D, G) and allogeneic (BALB/c) skins which were grafted on a seven months electroporated ZAP-/- recipient (E, H) and on an untreated ZAP-/- recipient (F, I). These sections have been analyzed by hematoxylin-eosin (H/E, 200X view), to observed the presence of infiltrating cells (G, H, I), and by immunofluorescence (100X view), using antibodies against the epithelial marker Keratin 5 (K5, green) and the T lymphocyte marker CD3, to characterize these infiltrating cells (D, E, F). Contrary to the non-rejected skins (D, F, G, I) harvested 100 days after transplantation, the dermis of BALB/c allogeneic skin graft rejected at 50% by the reconstituted C57BL/6 ZAP70-/- recipient contains numerous infiltrating cells (dark purple staining; H), characterized as CD3+ cells (E). TCR Valphan specific primer with a specific TCR constant alpha primer = ADVn
###end p 45
###begin p 46
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 249 260 249 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g006">Figure 6C-I</xref>
###xml 380 389 380 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g006">Figure 6C</xref>
###xml 526 529 526 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 531 543 531 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g006">Figure 6E, H</xref>
###xml 565 568 565 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 581 593 581 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g006">Figure 6F, I</xref>
###xml 629 641 629 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002059-g006">Figure 6D, G</xref>
###xml 671 672 671 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 801 804 801 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 932 935 932 935 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 975 982 975 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 880 884 <span type="species:ncbi:10090">mice</span>
###xml 936 940 <span type="species:ncbi:10090">mice</span>
To assess the capacity of the reconstituted C57/BL6 ZAP70-/- mice to mount an allogeneic immune response, wild type and seven and sixteen month reconstituted mice were compared for their ability to reject fully histoincompatible BALB/c skin grafts (Figure 6C-I). The reconstituted mice rejected their allogeneic grafts between day 10 and day 14, as fast as the wild-type control (Figure 6C). Histological examination of rejected skin allografts revealed a marked difference between the seven month reconstituted C57/BL6 ZAP-70-/- (Figure 6E, H) and untreated ZAP-70-/- recipients (Figure 6F, I) as well as the syngeneic control (Figure 6D, G). Indeed, infiltration of CD3+ cells in the skin dermis were found in the former but were virtually absent in the latter. Thus, the reconstituted C57/BL6 ZAP70-/- are able to develop an allogeneic response comparable to wild-type C57/BL6 mice. We can conclude that reconstituted C57BL/6 ZAP-/- mice possess T lymphocytes with normal in vivo functional properties, enabling them to respond to an OVA DNA vaccine and rapidly reject fully MHC-mismatched BALB/c skin grafts.
###end p 46
###begin title 47
Discussion
###end title 47
###begin p 48
###xml 292 301 292 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r in vivo</italic>
###xml 783 787 783 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Favard1">[19]</xref>
Various methods based on the use of viruses as biological vectors have been developed over the years for the delivery of DNA. However, after decades of research and development, gene therapy still lacks a safe and efficient method permitting DNA delivery. The use of electric pulses to deliver in vivo therapeutic molecules to organs has seen rapid development over the last few years and represents an increasingly attractive non-viral method. The exponential increase in number of publications on the subject over the last 10 years testifies to this interest. By using bibliographic resources, using electroporation and gene therapy as key words, we found that electrotransfer has been applied to all easily accessible organs and also to internal organs when combined with surgery [19]. However, the thymus, the primary lymphoid organ in which several natural mutations have been characterized to induce a blockage in T cell development, has never been targeted by electro gene delivery for gene therapy.
###end p 48
###begin p 49
###xml 516 519 516 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Fischer2">[2]</xref>
###xml 521 524 521 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Kohn1">[3]</xref>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Chinen1">[20]</xref>
The thymus is the organ in which haematopoietic precursors develop into competent T lymphocytes. To correct immunodeficiencies linked to natural mutations, transducing the therapeutic gene with a retroviral vector into hematopoietic stem cells (HSCs) has provided a proof of concept for gene therapy. However, because vectors are composed of retroviral portions including the LTR sequence that can activate additional viral sequences present in the vector, the development of alternative methods has been encouraged [2], [3], [20].
###end p 49
###begin p 50
###xml 100 107 100 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 904 908 904 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Golzio1">[21]</xref>
###xml 909 913 909 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Takahashi1">[23]</xref>
The method of electroporation we develop herein is based on a monopolar device to target the thymus in vivo without any incision. The classical procedure is simplified for two reasons: first, a single electrified needle is used to inject the plasmid and apply the electrical field, and second no surgical intervention is required. The method is also simpler and more economical than viral approaches. It allows the reduction of risks because only DNA is electrotransferred into the thymus. The electrical parameters that we defined lead to the targeting of thymocytes at various stages of differentiation. It has been shown that dividing cells are highly transfectable compared to quiescent ones, suggesting that DNA enters the nucleus upon the disassembly of the nuclear envelope during mitosis. Therefore, synchronizing the electrotransfer protocol with mitosis has been shown to improve gene delivery [21]-[23]. In our case, we do not need to synchronize since thymocytes are continuously in cell cycle. This biological process increases the efficiency of thymocyte electroporation within the thymus. Thus, these encouraging results led us to investigate the usefulness of this method for correcting T cell combined immunodeficiencies as proof of concept.
###end p 50
###begin p 51
###xml 142 143 142 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 146 147 146 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 170 173 170 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Kadlecek1">[6]</xref>
###xml 260 263 260 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 841 845 841 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Adjali1">[17]</xref>
###xml 847 851 847 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Adjali2">[24]</xref>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
The efficacy of this approach is in large part due to the reconstitution of a SCID phenotype where thymocyte development is blocked at the CD4+CD8+ double-positive stage [6]. We demonstrated that a direct electroporation of the ZAP-70 gene into thymi of ZAP-70-/- mice allows effective and rapid T cell reconstitution. Only two weeks later, CD4 and CD8 SP thymocyte differentiation occurred and significant numbers of T lymphocytes were present in the spleen and lymph nodes. Then, this non-viral approach achieved with nonsurgical intervention resulted in a significantly enhanced T cell reconstitution due to the direct targeting of the thymus. This observation is consistent with two recent studies which showed that intrathymic injection of either a ZAP-70 expressing lentiviral vector or WT HSCs enhances the kinetics of reconstitution [17], [24].
###end p 51
###begin p 52
###xml 631 635 620 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Pasqual1">[25]</xref>
###xml 637 641 626 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Hamrouni1">[26]</xref>
###xml 1408 1415 1397 1404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
###xml 704 708 <span type="species:ncbi:10090">mice</span>
###xml 796 800 <span type="species:ncbi:10090">mice</span>
###xml 865 869 <span type="species:ncbi:10090">mice</span>
The efficacy of reconstitution by our method is also characterized in periphery by the detection of significant numbers of CD4 and CD8 T lymphocytes that exhibit a diverse TCR repertoire. The TCR repertoire observed in the reconstituted mice is characterized by a large pool of both alha and beta chains, although some discrete differences in the uses of V regions are observed in comparison to wild type mice. For instance in 10 months old reconstituted mice, Valpha1 and Valpha5 were not detected, and Vbeta11 appeared under represented. The balance of the V uses in the repertoire is regulated during the ontogeny of the thymus [25], [26]. In as much as the transfection is carried out in young adult mice, thus later than the first steps of TCR alpha rearrangement in the thymus of wild type mice, the difference observed in the use of V genes in reconstituted mice may reflect changes in the regulation of TCR rearrangement and expression. Whatever the relative frequencies of the various V, the high degree of junctional variability at the CDR3 provides enough diversity to restore a fully functional TCR repertoire. Obviously in this model where thymocyte development is blocked at the DP stage, only transfected T lymphocytes can migrate and be functional at the periphery. Over the long-term, a peripheral partially diversified TCR repertoire was sufficient to provide functional T cells that mount in vivo immune responses to skin allografts and this response is specific to the alloantigens encountered (data not shown). Moreover, we monitored the persistence of long-lived T cells in periphery more than sixteen months after thymic electroporation and verified that both CD8 and CD4 T cells respond properly to an OVA DNA vaccine. Our data suggest that T cells persist for long periods in the periphery after their reconstitution by electro-gene transfer.
###end p 52
###begin p 53
###xml 154 161 154 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Tupin1">[27]</xref>
###xml 344 348 344 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Woods1">[28]</xref>
###xml 627 633 627 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad hoc</italic>
###xml 645 650 <span type="species:ncbi:9606">human</span>
It is also important to note that the electroporation does not impair a normal immune response, as shown by this study and as well as by previous work on in vivo electroporation of splenic T lymphocytes [27]. However, the safety of gene transfer by electroporation in terms of potential insertional mutagenesis remains to be fully investigated [28]. We propose that thymic electroporation represents an interesting method for immunodeficiency gene therapy, which evidently requires optimization for clinical application, such as a systematic study to identify the optimal electropulsing sequence, injection periodicity and the ad hoc device for human electro-gene transfer.
###end p 53
###begin p 54
We believed that this study is an exciting proof-of-principle that may advance the field of nonviral gene therapy. In addition, electrotransfer may also be used to efficiently deliver to the thymus a wide range of potentially therapeutic agents in addition to DNA, including proteins, oligonucleotides and siRNAs. An important feature of the monopolar electro-gene transfer resides in its potential application to other deep organs without surgery.
###end p 54
###begin title 55
Materials and Methods
###end title 55
###begin title 56
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 56
###begin p 57
###xml 69 72 69 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 98 101 98 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Kadlecek1">[6]</xref>
###xml 663 666 663 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
###xml 456 460 <span type="species:ncbi:10090">mice</span>
###xml 559 563 <span type="species:ncbi:10090">mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
###xml 738 742 <span type="species:ncbi:10090">mice</span>
C57/BL6 WT (Iffa Credo), BALB/c WT (Charles River) and C57/BL6 ZAP-70-/- (The Jackson Laboratory) [6] mice were bred and maintained under specific-pathogen-free conditions. All experiments were done in agreement with the French and European ethical rules. Thymic in vivo electro-gene transfer was performed at 3-6 weeks of age. Forty and twenty C57/Bl6 mice were transfected with pCMV-luc and pCMV-EGFP constructs, respectively. After 24 hours a subset of mice was sacrificed, thirty for the pCMV-luc and five for pCMV-EGFP for short term analysis, the other mice were sacrificed after one month for long-term analysis. T cell reconstitution experiments in ZAP-70-/- mice were performed in five independent assays including at least five mice.
###end p 57
###begin title 58
Expression plasmids
###end title 58
###begin p 59
###xml 55 58 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Two expression vectors containing the cytomegalovirus (CMV) promoter inserted upstream of the coding sequence of the firefly luciferase (Promega), and enhanced green fluorescent protein (Clontech laboratories) were used for the optimization of electrical parameters. For T cell reconstitution experiments, the pCMV-ZAP-70 plasmid (kindly provided by AM Lellouch; CIML, Marseille, France) was used to insert the ZAP-70 gene into the pCMV-IRES-EGFP (Clontech laboratories). Each plasmid was amplified in DH5alpha bacteria andpurified on Qiagen columns by the lipopolysaccharide free method (Qiagen). A plasmid concentration of 5 microg/microl was maintained as a stock in 0.9% NaCl. The National Center for Biotechnology Information (NCBI) unigene cluster IDs () for the ZAP-70 gene mentioned in the text is Mm.8038.
###end p 59
###begin title 60
Electroporation procedures
###end title 60
###begin p 61
Animals were anaesthetized by intraperitoneal injection with a mixture of ketamine (100 mg/kg body weight; Imalgene 500; Rhone-Merieux) and xylazine (10 mg/kg body weight; Rompun 2%; Centravet). A 10 microl formulation containing 10 microg of pCMV-luc or pCMV-EGFP DNA was injected with an insulin syringe in each thymic lobe and the current was immediately delivered, with a standard square wave electroporator BTX T820 (BTX, Inc). 10 microg of DNA was tested with various values of voltage (0-900 V) and 5 pulses of 100 microsec. For T cell reconstitution experiments, a 10 microl formulation of 30 microg of pCMV-ZAP-70-IRES-EGFP DNA was injected in each thymic lobe and then an electrical current of 5 pulses of 20 ms at 300 V was immediately applied. At the end of the experiment the animals were kept warm until recovery.
###end p 61
###begin title 62
Thymic protein extraction and luciferase assay
###end title 62
###begin p 63
###xml 419 435 419 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Photinus pyralis</italic>
###xml 419 435 <span type="species:ncbi:7054">Photinus pyralis</span>
The thymus was recovered and homogenized in 0.5 ml of lysis buffer (Promega) and centrifuged 10 min at 11000 rpm. Then, the supernatant was assayed for total proteins and luciferase activity with the luciferase assay kit from Promega for the measurement of light production during 10 sec interval in a TD20 luminometer (Turner design). The level of luciferase expression was quantified using commercial luciferase from Photinus pyralis (Boehringer-Mannhein).
###end p 63
###begin title 64
Bioluminescence imaging
###end title 64
###begin p 65
###xml 7 11 <span type="species:ncbi:10090">mice</span>
BALB/c mice were anesthetized with 4% isofluorane before the intraperitoneal injection of 125 mg/kg body weight of luciferin (sodium salt; Promega). Ten minutes after the luciferin injection, photons emitted from luciferase within the animal and transmitted through its tissues were collected and integrated for a 5 min period images acquired using the NightOWL LB 981 CCD camera (Berthold Technologies GmbH & Co). Pictures were taken, onto which the pseudocolor image representing the spatial distribution of the detected photons was superimposed. The signal intensities from manually derived regions of interest (ROI) were obtained and data were expressed as photon flux (counts/s). Background photon flux was defined from a ROI of the same size placed in a non luminescent area nearby the animal and then subtracted from the measured luminescent signal intensity.
###end p 65
###begin title 66
Immunofluorescence
###end title 66
###begin p 67
###xml 685 689 <span type="species:ncbi:9925">goat</span>
###xml 695 698 <span type="species:ncbi:10116">rat</span>
###xml 717 721 <span type="species:ncbi:9925">goat</span>
###xml 727 733 <span type="species:ncbi:9986">rabbit</span>
To identify the distribution and cells expressing the transfected gene, sections of 8 microm were prepared by cryosectioning after embedding the organs in OCT (Sakura Finetech) and mounted on glass slides. Sliced samples were kept in a humidified chamber and were not allowed to dry during staining. Sections were fixed with 4% paraformaldehyde (Sigma Aldrich) in phosphate buffer for one hour. Frozen sections were stained with anti-B220 hybridomas (RA6-6B2), anti-CD3 hybridomas (OKT3) (kindly provided by Dr. B Malissen, CIML, Marseille, France), unconjugated anti-peripheral LN addressin (PNAd) antibody (MECA-79) (Pharmingen) and anti-ZAP-70 (Santa Cruz biotechnology). Alexa 546-goat anti-rat IgG and Alexa 546-goat anti-rabbit (Molecular Probes) were used as secondary antibodies. As negative control, WT thymus, spleen and lymph-nodes were used in all experiments. Tissues were counterstained with 4', 6'-diamidino-2-phenylindole (DAPI) at 1 microg/ml and mounted with Mowiol fluorescent mounting medium (Calbiochem). Skin sections were also stained with the anti-CD3 hybridomas (OKT3) and the anti-keratin 5 (AF138; Covance Research, Berkeley, CA).
###end p 67
###begin title 68
Microscopy and Digital Imaging
###end title 68
###begin p 69
###xml 489 493 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Girish1">[29]</xref>
Fluorescent images were acquired by a Zeiss LSM 510 confocal microscope with a 515-525 nm bandpass filter set to view EGFP, a 560 nm longpass filter set to view alexa 546 and a 420 nm longpass filter set to view DAPI. All images were exposed using the same exposure time under the same magnification. Quantitative analysis of transfected cells distribution into thymus and secondary lymphoid organ sections was performed using ImageJ software (National Institutes of Health, Bethesda, Md) [29].
###end p 69
###begin title 70
Immunohistochemistry
###end title 70
###begin p 71
###xml 344 345 344 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 167 173 <span type="species:ncbi:9986">rabbit</span>
###xml 487 493 <span type="species:ncbi:9986">Rabbit</span>
Dessicated frozen sections were fixed with 4% paraformaldehyde (Sigma Aldrich) in phosphate buffer for one hour. Immunohistochemistry analysis was performed using the rabbit ABC staining system (Santa Cruz Biotechnology). Endogenous peroxidase activity was quenched by incubating slides for 10 min in 1% hydrogen peroxide diluted in deionized H20. Sections were incubated for one hour in 1.5% blocking serum in PBS for blocking non-specific binding performed before antibody incubation. Rabbit anti GFP polyclonal antibody (BD Biosciences) incubation was performed for 30 min at room temperature. Single-color histochemical detection was performed using an avidin-peroxidase conjugate system, and the antibody-enzyme complex was visualized with 3'3'-diaminobenzidene (DAB). Incubation times were carefully monitored to prevent saturation, thus favoring visualization of differences in expression levels. Sections were counterstained using Mayer's hematoxylin solution (Sigma Diagnostics), dehydrated through graded ethanol and cover slipped using Eukitt mounting medium (Sigma Aldrich) for examination. Skin sections were also counterstained using hematoxylin-eosin solutions. Images were taken using Zeiss, axiophot 2 microscope with Nikon digital camera DXm1200.
###end p 71
###begin title 72
Flow cytometry
###end title 72
###begin p 73
###xml 461 468 <span type="species:ncbi:9031">chicken</span>
One to two million thymocytes were first incubated with the 2.4G2 hybridoma supernatant to block nonspecific binding of labeled antibodies. Then, the cells were stained with a mixture of PE-labeled CD4 and APC-labeled CD8 mAbs (BD Pharmingen). Viable cells were examined using a FACScalibur flow cytometer and data analyzed with Cell Quest software (Becton Dickson). For intracellular IFN-gamma staining, blood cells stimulated overnight with OT-I OVA peptide (chicken OVA peptide 257-264 SIINFEKL) were first stained for PE-labeled CD4 and PerCP-labeled CD8 mAbs (BD Pharmingen) surface markers, followed by fixation in BD Cytofix/Cytoperm (BD biosciences). Staining was then performed with APC-conjugated anti-IFN-gamma Ab (BD Biosciences) in 1X BD Perm/Wash buffer. Cells were washed in 1X BD Perm/Wash buffer twice before resuspension in FACS buffer and analysis. For the repertoire analysis, PE-labeled TCRValpha2, TCRVbeta5.1-5.2, 8.1-8.2 and 11 were used in combination with PerCP-labeled CD8 and APC-labeled CD4 antibodies (BD Pharmingen).
###end p 73
###begin title 74
RT-PCR
###end title 74
###begin p 75
###xml 712 743 662 693 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCACATATGCACTGTCCCTGGTCTA-3&#8242;</named-content>
###xml 763 794 713 744 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGGTCGCTGTAGGGACTCTCGTACA-3&#8242;</named-content>
###xml 841 867 791 817 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGTCCAAAGGCAGAGCCCCA-3&#8242;</named-content>
###xml 883 909 833 859 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGCTGTCACCTTCGAGGTTA-3&#8242;</named-content>
###xml 963 987 913 937 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AACGACCCCTTCATTGAC-3&#8242;</named-content>
###xml 1007 1033 957 983 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCCACGAC ATACTCAGCAC-3&#8242;</named-content>
Total RNA was purified using TRIzol reagent (Gibco-BRL). Single-strand cDNA was synthesized by reverse transcription on 0.3-5 microg of total RNA using oligo(dT)25 and SuperScript II (Gibco-BRL) in a final volume of 20 microl. PCR reaction was performed in a PTC 200 Peltier Thermal Cycler (MJ research Inc) using 2 microl of the RT reaction product in a final volume of 50 microl, using the following conditions: 94degreesC for 3 min (1 cycle), 30 cycles of 94degreesC for 30 s, 66degreesC for 40 s, 72degreesC for 1 min, and 72degreesC for 10 min (1 cycle). Of the amplification product, 10 microl were resolved on a 1% agarose gel. The sequence primers used to detect specifically ZAP-70 are: forward primer: 5'-GCACATATGCACTGTCCCTGGTCTA-3' and reverse primer 5'-GGGTCGCTGTAGGGACTCTCGTACA-3' while EGFP was amplified with forward primer: 5'-AGTCCAAAGGCAGAGCCCCA-3' reverse primer 5'-CGCTGTCACCTTCGAGGTTA-3' and the housekeeping gene GAPDH with forward primer: 5'-AACGACCCCTTCATTGAC-3' and reverse primer 5'-TCCACGAC ATACTCAGCAC-3'.
###end p 75
###begin title 76
Western-blots
###end title 76
###begin p 77
###xml 395 401 <span type="species:ncbi:9986">rabbit</span>
###xml 432 437 <span type="species:ncbi:10090">mouse</span>
###xml 526 537 <span type="species:ncbi:3704">horseradish</span>
To analyze the protein expression of ZAP-70, thymi and spleens were crushed and cytosolic proteins of T cells were isolated by using the Nuclear Protein Extraction Kit (Panomics). Protein concentrations were measured using the Pierce BCA protein assay. Samples were electrophoresed on 10% SDS-polyacrylamide gel and transferred to Nitrocellulose membranes (BioRad) following incubation with the rabbit polyclonal anti-ZAP-70 or the mouse polyclonal anti-beta-tubulin (Santa Cruz biotechnology). Proteins were visualized using horseradish peroxidase-conjugated secondary antibody (Amersham Pharmacia Biotech,) and the enhanced chemiluminescence detection system (Pierce).
###end p 77
###begin title 78
Real time PCR
###end title 78
###begin p 79
###xml 133 134 133 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 701 703 671 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">27</sup>
###xml 1261 1263 1231 1233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">27</sup>
###xml 1386 1413 1356 1383 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CCATGGAATCTGGAACGTTCATC3&#8242;</named-content>
Total RNA from thymus or spleen samples was isolated using TRIzol reagent. Reverse transcription was done with SuperScript II RNase H- kit (Life Technologies) according to the manufacturer's instructions. Each sample was tested for G3PDH as a housekeeping gene, for CD3epsilon to determine T lymphocyte levels and for several T cell receptor variable alpha genes (TCRV) to evaluate the diversity of T cells. PCR of cDNA sample was carried out on a Light Cycler apparatus (Roche Diagnostics) under the following conditions: 95degreesC 10 min, 30 cycles (95degreesC 15 sec, 59degreesC 10 sec, 72degreesC 15 sec). The amplification efficiencies of the different PCR reactions were determined as described27. The values for the yield ranged from 85 to 87% among the different primer combinations. Melting curves of PCR products were determined according to the manufacturer's instructions (Roche Diagnostics). The specificity of the unique amplification product was established by melting curve analysis and by migration on agarose gels. Each sample was analyzed in duplicate in separate experiments. For CDR3 length distribution, TCRValpha1 diversity analysis was done using a TCR VA1 specific primer together with a specific TCR constant alpha primer as described27. Run off extensions were performed with the following internal TCR constant alpha specific fluorescent anti-sense primer (5'CCATGGAATCTGGAACGTTCATC3').
###end p 79
###begin title 80
Immunization and ELISA techniques
###end title 80
###begin p 81
###xml 64 68 64 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Maloy1">[30]</xref>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 591 596 <span type="species:ncbi:10090">mouse</span>
For DNA vaccination, mice were immunized in inguinal lymph node [30] with 10 microg of plasmid pDNK-OVA encoding the full-length OVA (kindly provided by Dr. P. Schuler). Plastic plates with 96 flat-bottomed wells were coated overnight at 4degreesC with 10 microg/ml of OVA to allow for the selective detection of high-affinity, OVA-specific IgG antibodies in the tested sera. Plates were washed with PBS, 0.05% Tween-20 and then blocked with 1% BSA+5% sucrose. After washing, dilutions of the test sera were added and incubated overnight at 4degreesC. Bound antibody was detected using anti-mouse gamma specific Alkaline phosphatase conjugated IgG (Amersham Pharmacia Biotech). Plates were developed with p-nitrophenyl-phosphate (Sigma-Aldrich), and absorbance was read at 405 nm.
###end p 81
###begin title 82
Skin grafting
###end title 82
###begin p 83
###xml 90 94 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-LeMoine1">[31]</xref>
###xml 96 100 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Poulin1">[32]</xref>
###xml 310 314 310 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002059-Billingham1">[33]</xref>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
Grafting tail skin onto the left flank of recipients was performed as previously reported [31], [32]. Briefly, skin grafts of approximately 1 cm diameter were prepared from tails of female mice and grafted onto the flanks of female recipients according to an adaptation of the method of Billingham and Medawar [33]. Petroleum gauze was placed over the graft, and sticking plaster was applied around the trunk. The bandages were removed after 10 days, and the grafts were monitored daily until day 30 and then every 2 days. Control syngeneic grafts (C57BL/6 donor skin on C57BL/6 recipient) always remained in excellent condition for more than 100 days.
###end p 83
###begin title 84
Supporting Information
###end title 84
###begin p 85
###xml 531 536 <span type="species:ncbi:10090">mouse</span>
Analysis of the thymus after monopolar electroporation. (A) The picture shows the healthy physical state of vital organs close to the thymus after injection and electroporation. Impact points in each thymic lobe are indicated by arrows. T: Thymus, H: Heart and L: Lung. The pCMV-luc plasmid was injected (0 V) or electroporated at 300 V and the luciferase expression was analyzed 24 hours later. In vivo bioluminescence indicated clear expression localized at the thymic site level. (B) Representative bioluminescence imaging of a mouse with an in vivo electroporated thymus with a luciferase DNA plasmid at 300 V in comparison to the 0 V condition. Levels of luminescence are indicated by false colors on a scale of 0 to 6000 units.
###end p 85
###begin p 86
(1.47 MB TIF)
###end p 86
###begin p 87
Click here for additional data file.
###end p 87
###begin p 88
Efficacy of thymocyte transfection after in vivo thymic electroporation. (A) Characterization of transfected cells by co-staining analysis with an anti-CD3 antibody in the thymus 24 hours and one month after thymic electroporation. Insets correspond to a higher magnification of EGFP transfected CD3 positive thymocytes. (B) The histogram shows percentages of EGFP transfected CD3+ thymocytes present within the cortex and the medulla 24 hours after electroporation and in the medulla/CMJ one month later. The mean percentage and standard deviation of 3 individual thymi (n = 3) were calculated.
###end p 88
###begin p 89
(2.32 MB TIF)
###end p 89
###begin p 90
Click here for additional data file.
###end p 90
###begin p 91
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 595 599 <span type="species:ncbi:10090">mice</span>
###xml 632 636 <span type="species:ncbi:10090">mice</span>
T lymphocytes exhibit an activated phenotype in reconstituted ZAP-70-/- mice. (A) The presence of EGFP T lymphocytes in reconstituted ZAP-70-/- mice was analyzed on splenic sections using a CD3 monoclonal antibody by confocal microscopy (upper panel). A nuclear counterstain (DAPI, blue) shows that transfected T lymphocytes are correctly localized in the white pulp (200X view). A higher magnification of transfected T lymphocytes was also presented (630X view). The lower panel shows a Western blot analysis of ZAP-70 protein levels in total thymocytes from spleens in WT, ZAP-70-/- deficient mice and in two weeks electroporated mice at 300 V (B) The phenotype of T lymphocytes was determined by using anti-CD62L and CD44 antibodies. The percentage of positively stained cells is indicated in each histogram.
###end p 91
###begin p 92
(2.63 MB TIF)
###end p 92
###begin p 93
Click here for additional data file.
###end p 93
###begin p 94
###xml 583 587 <span type="species:ncbi:10090">mice</span>
###xml 788 792 <span type="species:ncbi:10090">mice</span>
###xml 1080 1084 <span type="species:ncbi:10090">mice</span>
###xml 1153 1157 <span type="species:ncbi:10090">mice</span>
###xml 1196 1200 <span type="species:ncbi:10090">mice</span>
The sizes of the CDR3 were analysed by PCR followed by gel electrophoresis. The figure displays representative experiments of the CDR3 analysis of TCR transcripts for alpha chain bearing Valpha1. The relative intensity of the bands (y axis) was plotted as a function of the migration time in the electrophoresis (x axis) which is proportional to the size of CDR3. In each profile, the peaks corresponding to the reading frame are indicated. In WT, the spectral distribution of the sizes is representative of polyclonal composition of the TCR Valpha1 transcripts. In ZAP-70 deficient mice, no TCR transcripts are found in the spleen, whereas a few peaks of TCR Valpha1 transcripts are detected in the thymus, which are issued from non productive transcription known to take place in these mice. After electroporation of ZAP-70 plasmid (ZAP-70-/- 300 V), TCR transcripts bearing 1alphaV are detected in the thymus as well as in the spleen. The spectral distributions of the CDR3 sizes are, and on the one hand, similar in the thymus and the spleen of ZAP-70-/- 300 V electroporated mice, and on the other similar for WT and ZAP-70-/- 300 V electroporated mice. Thus, ZAP-70-/- 300 V electroporated mice are reconstituted with a polyclonal population of T cells which expressed a wide repertoire of TCR.
###end p 94
###begin p 95
(0.61 MB TIF)
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin p 97
Representative dot plots of TCRValpha2 and indicated TCRVbeta usage in splenic CD8 and CD4 T cells populations.
###end p 97
###begin p 98
(1.57 MB TIF)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
The authors would like to thank C. Moretti (IBDM, Marseille, France) and A. Serge (CIML, Marseille, France) for their assistance in microscopy analysis, N. Platet (Laboratoire de Neurobiophysique-UJFG, Grenoble, France) for her assistance in the electroporation procedure and P. Schuler (CMU, Geneva, Switzerland) for her assistance in immunization in inguinal lymph nodes, A. Da Riz (U823, Grenoble, France) for skillful assistance in PCR, and M. Buferne (CIML) for help with the bioluminescence measurements. We gratefully acknowledge Dr. A-M Schmitt-Verhulst (CIML) for critical reading of the manuscript and Dr. D. Scherman (ENSCP, Paris, France) for helpful discussions.
###end p 100
###begin title 101
References
###end title 101
###begin article-title 102
Primary immunodeficiency diseases: an experimental model for molecular medicine.
###end article-title 102
###begin article-title 103
Gene therapy of severe combined immunodeficiencies.
###end article-title 103
###begin article-title 104
Occurrence of leukaemia following gene therapy of X-linked SCID.
###end article-title 104
###begin article-title 105
Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research.
###end article-title 105
###begin article-title 106
Electroporation-enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases.
###end article-title 106
###begin article-title 107
Differential requirements for ZAP-70 in TCR signaling and T cell development.
###end article-title 107
###begin article-title 108
Muscle transfection by electroporation with high-voltage and short-pulse currents provides high-level and long-lasting gene expression.
###end article-title 108
###begin article-title 109
A central role for thymic emigrants in peripheral T cell homeostasis.
###end article-title 109
###begin article-title 110
###xml 40 46 <span type="species:ncbi:3750">apples</span>
Negative selection-clearing out the bad apples from the T-cell repertoire.
###end article-title 110
###begin article-title 111
###xml 66 69 <span type="species:ncbi:10116">rat</span>
Three-dimensional ultrastructure of the perivascular space in the rat thymus.
###end article-title 111
###begin article-title 112
Regulation of thymocyte development from immature progenitors.
###end article-title 112
###begin article-title 113
Lymphostromal interactions in thymic development and function.
###end article-title 113
###begin article-title 114
Intravital microscopy comparing T lymphocyte trafficking to the spleen and the mesenteric lymph node.
###end article-title 114
###begin article-title 115
Homing and cellular traffic in lymph nodes.
###end article-title 115
###begin article-title 116
Essential role for ZAP-70 in both positive and negative selection of thymocytes.
###end article-title 116
###begin article-title 117
High-efficiency gene transfer into skeletal muscle mediated by electric pulses.
###end article-title 117
###begin article-title 118
Intrathymic administration of hematopoietic progenitor cells enhances T cell reconstitution in ZAP-70 severe combined immunodeficiency.
###end article-title 118
###begin article-title 119
Both TCR alpha and TCR delta chain diversity are regulated during thymic ontogeny.
###end article-title 119
###begin article-title 120
Electrotransfer as a non viral method of gene delivery.
###end article-title 120
###begin article-title 121
Successes and risks of gene therapy in primary immunodeficiencies.
###end article-title 121
###begin article-title 122
Cell synchronization effect on mammalian cell permeabilization and gene delivery by electric field.
###end article-title 122
###begin article-title 123
###xml 36 41 <span type="species:ncbi:9606">human</span>
Optimization of the transfection of human endothelial cells by electroporation.
###end article-title 123
###begin article-title 124
Efficient introduction of a gene into hematopoietic cells in S-phase by electroporation.
###end article-title 124
###begin article-title 125
In vivo correction of ZAP-70 immunodeficiency by intrathymic gene transfer.
###end article-title 125
###begin article-title 126
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
Quantitative and qualitative changes in V-J alpha rearrangements during mouse thymocytes differentiation: implication for a limited T cell receptor alpha chain repertoire.
###end article-title 126
###begin article-title 127
T cell receptor gene rearrangement lineage analysis reveals clues for the origin of highly restricted antigen-specific repertoires.
###end article-title 127
###begin article-title 128
###xml 27 33 <span type="species:ncbi:10090">murine</span>
Non-viral gene transfer of murine spleen cells achieved by in vivo electroporation.
###end article-title 128
###begin article-title 129
Gene therapy: therapeutic gene causing lymphoma.
###end article-title 129
###begin article-title 130
Affordable image analysis using NIH Image/Image
###end article-title 130
###begin article-title 131
Intralymphatic immunization enhances DNA vaccination.
###end article-title 131
###begin article-title 132
###xml 82 86 <span type="species:ncbi:10090">mice</span>
IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice.
###end article-title 132
###begin article-title 133
Interleukin-9 stimulates the production of interleukin-5 in CD4+ T cells.
###end article-title 133
###begin article-title 134
The technique of free skin grafting in mammals.
###end article-title 134
###begin p 135
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 135
###begin p 136
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by Institut National de la Sante Et de la Recherche Medicale (INSERM). M. Irla is supported by a PhD fellowship from the Association pour la Recherche sur le Cancer (ARC) and M. Saade is supported by a grant from the Association Francaise contre les Myopathies (AFM). We acknowledge Ligue Contre le Cancer en Isere and the ARC for their help in obtaining equipment necessary for this work.
###end p 136

